Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, the discussions demonstrate a balanced, engaged attitude, with examples like references to the importance of cystatin C for accurate GFR estimation and genetic testing support, emphasizing the guideline's influence on practice. The tone varies from supportive to inquisitive, showing an active community analyzing its implications.
Most discussions acknowledge and support key recommendations, such as using combined creatinine and cystatin C equations and genetic testing, indicating general agreement with the guideline's updates.
Posts reflect moderate interest, highlighting specific aspects like new testing methods, implications for clinical practice, and variations in outcomes, but some show more technical focus than widespread enthusiasm.
Many discussions delve into detailed interpretations, referencing trials, recommendations for European labs, and implications for treatment, demonstrating active engagement.
The widespread sharing of summaries, expert commentaries, and educational webinars suggests the guideline is viewed as impactful, influencing clinical approaches and inspiring further discussions.
The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using equations that include both creatinine and cystatin C for more accurate GFR estimation and risk assessment in CKD. https://t.co/BxBTuSjaU0 https://t.co/qcPbJompaT
Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M07AMw8RAL (FREE) @NishaKidneyDoc @KCavanaugh_MD @Delgadockdny @estrella_khrc @cybeleg1 @HollyMarieMD @WendyStPeter002 @KatherineTuttl8 @jwilliamMD https://t.co/6HlHxEE7QN
Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns https://t.co/JdhSCSkEfQ #CKD #kidneydisease https://t.co/WjapYGKhEF
Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD in children and adults
Join us for @ipnajc: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Link to the article: https://t.co/i4khd9AqKN Date: 24/7/24 Time: 11am ET/ 5pm CET/ 9pm IST Register here: https://t.co/SbROxMtmRr https://t.co/U0lIhHxHpi
Making the right food swaps can help support healthy creatinine levels. This video explores nutrition strategies from KDOQI's 2020 guidelines for chronic kidney disease management, focusing on dietary protein, energy…
This video discusses the 2018 guideline developed by major health organizations, providing evidence-based recommendations for assessing, preventing, and managing high blood cholesterol to reduce cardiovascular risk. It…
This video reviews the 2024 nephrology and hypertension study highlights, focusing on semaglutide's benefits. The study shows semaglutide significantly reduces major cardiovascular events in overweight or obese…
Dr Deborah J Clegg and Dr Biff Franklin Palmer discuss topical treatment approaches for hyperkalemia management based on their review paper, highlighting the importance of electrolyte regulation in kidney health.
Prof. van der Giet, Prof. Chenot, and Prof. Kuhlmann discuss the interdisciplinary outpatient care of chronic kidney disease (CKD) patients, focusing on S3 guidelines for managing patients not requiring kidney…
Dr Sander van Doorn and Dr Christian Ruff discuss current and future treatment options for stroke prevention in atrial fibrillation patients, focusing on FRAILAF and AZALEA studies exploring anticoagulation therapies…
Dr Nilufar Mohebbi and Dr Navdeep Tangri review phase 3 studies on renal acidosis treatments, focusing on recent research from the PRESERVETransplant and VALOR-CKD trials, highlighting challenges and advancements in…
Prof Jha, Dr Luyckx, and Prof Torra discuss the impact of Chronic Kidney Disease on global health, emphasizing recent consensus guidelines focusing on early detection, personalized treatment, and multidisciplinary…
Proper nutrition is crucial for managing chronic kidney disease, helping to slow progression and enhance quality of life. This video highlights key dietary strategies including protein, sodium, and potassium management…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using equations that include both creatinine and cystatin C for more accurate GFR estimation and risk assessment in CKD. ja.ma/4nHqEvg
The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using equations that include both creatinine and cystatin C for more accurate GFR estimation and risk assessment in CKD. https://t.co/2S4yVsEN64 https://t.co/1hXTr1BnpL
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
RT @JAMA_current: The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using e…
The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using equations that include both creatinine and cystatin C for more accurate GFR estimation and risk assessment in CKD. ja.ma/43QS5vy
The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease recommends using equations that include both creatinine and cystatin C for more accurate GFR estimation and risk assessment in CKD. https://t.co/BxBTuSjaU0 https://t.co/qcPbJompaT
It's interesting to notice the differences in outcomes by eGFR by Cr/Cys-Cr. #nephJC
4/12 Los pacientes con ERC sufren una alta carga sintomática que afecta su calidad de vida. Suelen tener prioridades distintas al equipo médico. DOI: 10.1053/j.ajkd.2021.08.021 DOI: 10.1016/j.kint.2023.10.018 https://t.co/8weNz4a1JK
RT @lconcepcionmd: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD - American Jo…
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD - American Journal of Kidney Diseases https://t.co/SnIMM7zHrc
RT @lconcepcionmd: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD - American Jo…
RT @lconcepcionmd: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD - American Jo…
RT @lconcepcionmd: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD - American Jo…
RT @lconcepcionmd: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD - American Jo…
Corrigendum to "KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis." Kidney International 2024;105(3S):S71-S116
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD - American Journal of Kidney Diseases https://t.co/SnIMM7zHrc
RT @PStoneOftheYear: Important publication from the working group led by @etiennecavalier Recommendations for European laboratories based…
RT @PStoneOftheYear: Important publication from the working group led by @etiennecavalier Recommendations for European laboratories based…
RT @PStoneOftheYear: Important publication from the working group led by @etiennecavalier Recommendations for European laboratories based…
Important publication from the working group led by @etiennecavalier Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease - Read on https://t.co/EWuiTdiIwi @degruyter_brill
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD - American Journal of Kidney Diseases
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @gunnar_heine: @AKronbichler In line with our 2024 annual review, we would love to remind all international colleages of our webinar on…
RT @MarkusAtHome: TOP 16: VALOR-CKD by Drs. @NavTangri @LAInker et al. https://t.co/tIHMIz6d5M Treatment of renal acidosis with Veverimer…
TOP 16: VALOR-CKD by Drs. @NavTangri @LAInker et al. https://t.co/tIHMIz6d5M Treatment of renal acidosis with Veverimer was not nephroprotective in CKD G 3b - G 4 patients. Check out our webinar with Dr. Tangri & Dr. Mohebbi on MARKUS@HOMe
@AKronbichler In line with our 2024 annual review, we would love to remind all international colleages of our webinar on global nephrology with @vjha126 @valerie_luyckx @torra_roser https://t.co/SNpY3SJ3BM
Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic #Kidney Disease https://t.co/t1tI2ZLU4b
RT @AJKDonline: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M…
RT @AJKDonline: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M…
RT @AJKDonline: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M…
RT @AJKDonline: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M…
RT @AJKDonline: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M…
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD - American Journal of Kidney Diseases https://t.co/HCdwX3SwoE
RT @AJKDonline: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M…
RT @AJKDonline: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M…
RT @AJKDonline: KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M…
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD https://t.co/M07AMw8RAL (FREE) @NishaKidneyDoc @KCavanaugh_MD @Delgadockdny @estrella_khrc @cybeleg1 @HollyMarieMD @WendyStPeter002 @KatherineTuttl8 @jwilliamMD https://t.co/6HlHxEE7QN
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD bit.ly/KDOQICKD2024 (FREE)
KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD bit.ly/KDOQICKD2024 (FREE)
RT @ERAkidney:
Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @ERAkidney:
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
Check out our #Link to a presentation by Dr @adeeralevin (@UBC) on changes and key messages from the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Click HERE: https://t.co/NdcEiHl8fU @RenalSociety @ANZSN https://t.co/NsEeLCMaNo
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
RT @edgarvlermamd: Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
Who is a candidate for SGLT2 inhibitors (SGLT2i) in CKD⁉️
Not in San Diego tonight? Watch 2023 and 2024 Late-Breaking Trials on Renal Acidosis at HOMe with @NavTangri and Nilufar Mohebbi @MarcusSaemann @dgfn_ev @oegnephro @com_SFNDT https://t.co/mSCZ1byDKy via @YouTube
RT @hjanders_hans: Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evalua…
RT @hjanders_hans: Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evalua…
RT @hjanders_hans: Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evalua…
RT @hjanders_hans: Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evalua…
RT @hjanders_hans: Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evalua…
RT @hjanders_hans: Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evalua…
RT @hjanders_hans: Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evalua…
RT @hjanders_hans: Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evalua…
RT @hjanders_hans: Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evalua…
Now open access in @NDTsocial A commentary from ERBP (ERA) on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD in children and adults
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
RT @edgarvlermamd: SGLT2i indications in CKD #Nephpearls
Top 10 Takeaways for Nephrologists on the Management of People with CKD from the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease https://t.co/s0HTiNETyd https://t.co/RzrBmIYtxf
RT @md_abdulqader83: Join us for @ipnajc: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disea…
RT @md_abdulqader83: Join us for @ipnajc: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disea…
RT @md_abdulqader83: Join us for @ipnajc: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disea…
RT @md_abdulqader83: Join us for @ipnajc: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disea…
RT @md_abdulqader83: Join us for @ipnajc: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disea…
RT @md_abdulqader83: Join us for @ipnajc: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disea…
Join us for @ipnajc: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Link to the article: https://t.co/i4khd9AqKN Date: 24/7/24 Time: 11am ET/ 5pm CET/ 9pm IST Register here: https://t.co/SbROxMtmRr https://t.co/U0lIhHxHpi
Capotondo, M., & Musso, C. (2019). Nephroprevention in the Elderly. En Clinical Nephrogeriatrics. Springer. Kidney Disease: Improving Global Outcomes CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int.
Did you know? @goKDIGO guidelines support genetic testing for most #CKD patients to help identify a cause, even without a family history. They highlight six key clinical scenarios and actionable gene categories, like those in #Natera’s #Renasight panel. https://t.co/TwrdH6zHcq https://t.co/d3iLxLaOHv
Did you know? @goKDIGO guidelines support genetic testing for most #CKD patients to help identify a cause, even without a family history. They highlight six key clinical scenarios and actionable gene categories, like those in #Natera’s #Renasight panel. https://t.co/LVVbPU1RT8 https://t.co/icNsBMTlUW
RT @gunnar_heine: CKD & The Global Public Health Agenda @vjha126 @rosertorras @valerie_luyckx @dgfn_ev @com_SFNDT @oegnephro @AKronbichler…
RT @ewa_pawlowicz: An absolute must-watch! Thank you @torra_roser @valerie_luyckx @vjha126 @gunnar_heine and @AKronbichler for this eye-ope…
RT @ewa_pawlowicz: An absolute must-watch! Thank you @torra_roser @valerie_luyckx @vjha126 @gunnar_heine and @AKronbichler for this eye-ope…
An absolute must-watch! Thank you @torra_roser @valerie_luyckx @vjha126 @gunnar_heine and @AKronbichler for this eye-opening discussion! https://t.co/xas00uJ9Wa
RT @gunnar_heine: CKD & The Global Public Health Agenda @vjha126 @rosertorras @valerie_luyckx @dgfn_ev @com_SFNDT @oegnephro @AKronbichler…
CKD & The Global Public Health Agenda @vjha126 @rosertorras @valerie_luyckx @dgfn_ev @com_SFNDT @oegnephro @AKronbichler https://t.co/xT5gSwlNqG via @YouTube
@dgfn_ev Nicht perniziöse Anämie, sondern Primärer Aldosteronismus ☺️ (Nephrologe, bleib bei Deinen Leisten). Zuvor aber: Orbis non sufficit am 21.06.2024! https://t.co/CxrrUK9rmr
@Nephro_Sparks @KidneyInCVD @goKDIGO @LeslieGewin @RangaswJ @AHAScience And what about the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease? https://t.co/pfJPWINPJM
RT @gunnar_heine: Summit Meeting @ HOMe: Treatment of Hyperkaelemia with Prof. Deborah Clegg (El Paso, TX) and Prof. Biff B. Palmer (Dalla…
RT @gunnar_heine: Summit Meeting @ HOMe: Treatment of Hyperkaelemia with Prof. Deborah Clegg (El Paso, TX) and Prof. Biff B. Palmer (Dalla…
RT @gunnar_heine: Summit Meeting @ HOMe: Treatment of Hyperkaelemia with Prof. Deborah Clegg (El Paso, TX) and Prof. Biff B. Palmer (Dalla…
Summit Meeting @ HOMe: Treatment of Hyperkaelemia with Prof. Deborah Clegg (El Paso, TX) and Prof. Biff B. Palmer (Dallas, TX) A pleasure to host two legends in electrolyte and nutrition research together with @AKronbichler @NDTsocial https://t.co/Nig2gibaYZ via @YouTube
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @ZHeart11768530:
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @ZHeart11768530:
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
RT @Kidney_Int: Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Diseas…
Executive summary of the #KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns https://t.co/JdhSCSkEfQ #CKD #kidneydisease https://t.co/WjapYGKhEF
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic #Kidney Disease: known knowns and known unknowns | https://t.co/G1YGETkFei #kidneydisease #CKD
RT @ZHeart11768530:
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @goKDIGO: KDIGO is releasing several new resources to complement the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Manag…
RT @NefroClassMx: 4/4
RT @rksanti: ✳️Ya está la nueva guía de practica clínica en enfermedad renal crónica
RT @rksanti: ✳️Ya está la nueva guía de practica clínica en enfermedad renal crónica
Guía de practica clínica en enfermedad renal crónica KDIGO 2024 https://t.co/S8yqLFRBOT https://t.co/bpv0Jq8R2n
4/4
RT @rksanti: ✳️Ya está la nueva guía de practica clínica en enfermedad renal crónica
RT @rksanti: ✳️Ya está la nueva guía de practica clínica en enfermedad renal crónica
RT @rksanti: ✳️Ya está la nueva guía de practica clínica en enfermedad renal crónica
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD #WorldKidneyDay 2️⃣
RT @rksanti: ✳️Ya está la nueva guía de practica clínica en enfermedad renal crónica
RT @rksanti: ✳️Ya está la nueva guía de practica clínica en enfermedad renal crónica
✳️Ya está la nueva guía de practica clínica en enfermedad renal crónica
KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis #Nephpearls
J
SN
JB
IZ
JJ
F
OF
JS
PF
DN
MF
N
AB
NI
HR
KC
Z
TS
A
HM
AD
CI
JF
SM
D
LM
NP
L
MS
日N
AF
DH
H
YF
L
DM
NT
MC
MK
GP
RP
?
TW
MP
A
VH
NH
GR
DB
SC
NS
IM
CV
GB
KL
MY
ER
A
ME
PY
DJ
DA
TA
?
SH
HH
BL
JV
DN
UK
DG
AC
BB
PF
TK
K
MR
GB
GM